Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium gluconate for abdominal pain due to lead toxicity in opioid users
IRCT20171009036661N2Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of calcium gluconate in lead poisoning, sponsored by Kerman University of Medical Sciences. Primary endpoints: Abdominal pain and Lead poisoning. Started Jun 2017; status: completed.
02
Drugs
calcium gluconate
03
Conditions
lead poisoning
Beyond the preview
Go deeper on IRCT20171009036661N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171009036661N2.